INTRODUCTION
Biologic therapies have transformed the management of severe asthma, particularly in type 2-high disease, but important unmet needs remain. Incomplete responses, uncertainty in treatment positioning, and the lack of effective options for non-type 2 or mixed inflammatory endotypes continue to limit the achi...
R. Poto, R. Chan, G. Paoletti et al.· Expert Opinion on Biological...· 0 citations
INTRODUCTION
Despite significant advances in precision medicine, managing severe asthma remains a major clinical challenge. Small airway dysfunction (SAD) is a crucial determinant of poor symptom control, airway remodeling, and frequent exacerbations. While conventional spirometry primarily assesses large airway mechan...
F. Menzella, R. Chan, M. Cottini et al.· Expert Review of Respiratory...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.